Related Experiment Videos

Changes in copper and ceruloplasmin in chronic renal insufficiency treated by hemodialysis and peritoneal dialysis

Nephron
|January 1, 1978
PubMed

Insights

Chronic renal insufficiency does not alter serum copper or ceruloplasmin levels. However, hemodialysis and peritoneal dialysis patients show increased serum copper, potentially due to membrane copper release.

Area of Science:

  • Nephrology
  • Clinical Chemistry

Background:

  • Chronic renal insufficiency (CRI) affects various biochemical parameters.
  • The role of copper and ceruloplasmin in CRI is not fully understood.

Purpose of the Study:

  • To investigate serum copper and ceruloplasmin levels in patients with chronic renal insufficiency.
  • To evaluate the impact of hemodialysis and peritoneal dialysis on these parameters.

Main Methods:

  • Serum samples were analyzed from 68 patients with CRI.
  • Patients were categorized into groups undergoing hemodialysis or periodic peritoneal dialysis.

Main Results:

  • Chronic renal insufficiency itself did not significantly alter serum copper or ceruloplasmin.
  • Hemodialysis led to a progressive increase in serum copper and ceruloplasmin, linked to membrane copper leaching (44.44% release).
  • Peritoneal dialysis also showed an increase in serum copper during treatment, with no clear explanation provided.

Conclusions:

  • Serum copper and ceruloplasmin are not elevated in patients with chronic renal insufficiency solely due to the condition.
  • Dialysis procedures, particularly hemodialysis, can lead to increased serum copper and ceruloplasmin levels.
  • The mechanism behind increased serum copper during peritoneal dialysis requires further investigation.

Related Concept Videos